Medmira Capital Ltd. 4
4 · HCW Biologics Inc. · Filed Jul 23, 2021
Insider Transaction Report
Form 4
Medmira Capital Ltd.
10% Owner
Transactions
- Conversion
Common Stock
2021-07-22+730,519→ 3,587,661 total - Conversion
Series B Redeemable Preferred Stock
2021-07-22−2,857,142→ 0 total→ Common Stock (2,857,142 underlying) - Conversion
Common Stock
2021-07-22+2,857,142→ 2,857,142 total - Conversion
Series C Redeemable Preferred Stock
2021-07-22−730,519→ 0 total→ Common Stock (730,519 underlying)
Footnotes (2)
- [F1]Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
- [F2]Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.